FLX Bio's Series A Round

FLX Bio raised a round of funding on August 31, 2015.

FLX Bio is a biotechnology company focused on the creation, development and commercialization of novel anti-cancer therapeutics. Toward this end, the company is leveraging unexploited insights in immu…

Articles about FLX Bio's Series A Round: